Convergence Investment Partners’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-294
Closed -$17K 398
2018
Q1
$17K Buy
+294
New +$18.5K ﹤0.01% 619
2015
Q1
Sell
-3,790
Closed -$204K 364
2014
Q4
$204K Sell
3,790
-8
-0.2% -$450 0.03% 338
2014
Q3
$215K Buy
+3,798
New +$225K 0.03% 337
2014
Q2
Sell
-4,828
Closed -$269K 373
2014
Q1
$269K Sell
4,828
-1,622
-25% -$84.3K 0.04% 310
2013
Q4
$346K Sell
6,450
-1,370
-18% -$72.9K 0.06% 290
2013
Q3
$411K Sell
7,820
-2,144
-22% -$113K 0.09% 214
2013
Q2
$513K Buy
+9,964
New +$549K 0.13% 193

Other funds holding BTI

Convergence Investment Partners's BTI Position: Q2 2018 in Review

Convergence Investment Partners sold out of British American Tobacco (BTI) in Q2 2018, closing a stake of 294 shares — an estimated $17K sold.

Convergence Investment Partners first reported a position in BTI in Q2 2013 and held it in 7 quarters. The position peaked at $513K in Q2 2013. 520 funds tracked by Wall St. Rank hold BTI as of Q2 2018.

  • Convergence Investment Partners reported no remaining British American Tobacco position as of Q2 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 294 British American Tobacco shares in Q2 2018, an estimated $17K.
  • Convergence Investment Partners first reported a position in British American Tobacco in Q2 2013 and held it in 7 quarters.
  • Convergence Investment Partners's British American Tobacco position peaked at $513K in Q2 2013.
  • 520 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.